Purchases and Sales Made in Q1 2024 in Ab Cellera Biologics Inc. (ABCL)
This table provides information about the institutional ownership of Ab Cellera Biologics Inc. (ABCL) during Q1 2024. The information is specifically focused on institutions that hold shares of AbCellera Biologics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 16, 2024
Q1 2024
|
National Asset Management, Inc.
Boca Raton, FL |
SELL
|
- |
-9K- 46.15% |
$38.6K - $53.7K
|
10.5K
$29.7K
|
|
|
May 15, 2024
Q1 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-10.6K- 2.31% |
$45.7K - $63.6K
|
450K
$1.27M
|
|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-14.4K- 8.41% |
$61.9K - $86.2K
|
157K
$445K
|
|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-16.5K- 4.04% |
$70.9K - $98.6K
|
392K
$1.11M
|
|
|
May 14, 2024
Q1 2024
|
Stansberry Asset Management, LLC
New York, NY |
SELL
|
- |
-19.2K- 17.05% |
$82.3K - $114K
|
93.3K
$264K
|
|
|
May 13, 2024
Q1 2024
|
Jump Financial, LLC
Chicago, IL |
SELL
|
- |
-25.7K- 10.37% |
$110K - $153K
|
222K
$628K
|
|
|
May 15, 2024
Q1 2024
|
Graham Capital Management, L.P.
Rowayton, CT |
SELL
|
- |
-27.6K- 36.73% |
$118K - $165K
|
47.6K
$135K
|
|
|
May 10, 2024
Q1 2024
|
Credit Suisse Ag
Zurich, V8 |
SELL
|
- |
-30.9K- 0.68% |
$133K - $185K
|
4.55M
$12.9M
|
|
|
May 10, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-38.5K- 9.41% |
$165K - $230K
|
371K
$1.05M
|
|
|
May 06, 2024
Q1 2024
|
Duality Advisers, LP
Miami, FL |
SELL
|
- |
-42.9K- 38.67% |
$184K - $256K
|
68.1K
$193K
|
|
|
Apr 29, 2024
Q1 2024
|
Principal Financial Group Inc
Des Moines, IA |
SELL
|
- |
-77K- 69.24% |
$330K - $460K
|
34.2K
$96.8K
|
|
|
May 07, 2024
Q1 2024
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
SELL
|
- |
-114K- 33.91% |
$489K - $680K
|
222K
$628K
|
|
|
May 15, 2024
Q1 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-145K- 59.38% |
$620K - $863K
|
98.9K
$280K
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-162K- 29.34% |
$695K - $967K
|
390K
$1.1M
|
|
|
May 14, 2024
Q1 2024
|
Belmont Capital, LLC
|
SELL
|
- |
-250K- 49.02% |
$1.07M - $1.49M
|
260K
$736K
|
|
|
May 03, 2024
Q1 2024
|
Gsa Capital Partners LLP
London, X0 |
SELL
|
- |
-265K- 75.44% |
$1.13M - $1.58M
|
86.1K
$244K
|
|
|
May 14, 2024
Q1 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-302K- 9.69% |
$1.3M - $1.8M
|
2.82M
$7.97M
|
|
|
May 03, 2024
Q1 2024
|
Intellectus Partners, LLC
San Francisco, CA |
SELL
|
- |
-346K- 38.94% |
$1.48M - $2.06M
|
542K
$1.53M
|
|
|
May 15, 2024
Q1 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-395K- 65.67% |
$1.69M - $2.36M
|
206K
$584K
|
|
|
May 01, 2024
Q1 2024
|
Baillie Gifford & CO
|
SELL
|
- |
-865K- 3.6% |
$3.71M - $5.16M
|
23.2M
$65.6M
|
|
|
May 14, 2024
Q1 2024
|
Lazard Asset Management LLC
New York, NY |
SELL
|
- |
-1.39M- 40.8% |
$5.97M - $8.31M
|
2.02M
$5.72M
|
|
|
May 13, 2024
Q1 2024
|
Fil LTD
Hamilton, D0 |
SELL
|
- |
-1.81M- 96.53% |
$7.77M - $10.8M
|
65.1K
$184K
|